NCT03902912View on ClinicalTrials.gov

Effect of Prednisolone Treatment on Uterine Natural Killer Cells

PHASE3RecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

July 30, 2019

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2028

Conditions
Recurrent Miscarriage
Interventions
DRUG

Prednisolone

prednisolone oral 10 mg/day from day one of the subsequent menstrual cycle to day LH 7 of that cycle. Then, the participants will be given a tailing off dose of 5 mg/day for 3 days followed by 2 mg/day for 3 days and then 1 mg/day for 3 days.

Trial Locations (1)

Unknown

RECRUITING

The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT03902912 - Effect of Prednisolone Treatment on Uterine Natural Killer Cells | Biotech Hunter | Biotech Hunter